Plasma NT-proBNP levels provide prognostic information in a variety of cardiovascular settings, including heart failure with reduced37 or preserved ejection fraction38, coronary heart disease39, and atrial fibrillation40, indicating the clinical utility of this molecule as a biomarker for myocyte stress21. Here, NPPB is linked to heart failure.